The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel three-biomarker signature (CA-62, CEA, CYFRA 21-1) and early-stage NSC lung cancer detection.
 
Janneta Tcherkassova
Patents, Royalties, Other Intellectual Property - RU2735918C2, US20220057401A1 United States, WO2019235973A1 WIPO (PCT) Set of reagents for detecting a marker of epithelial carcinomas Abstract The invention relates to the new application of medicine, in particular to the laboratory cancer diagnostics (Inst)
 
Sergei Tsurkan
No Relationships to Disclose
 
Anna Prostyakova
No Relationships to Disclose
 
Evgueni Klinski
No Relationships to Disclose
 
Marina Sekacheva
No Relationships to Disclose
 
Alexander Boroda
No Relationships to Disclose
 
Ricardo Moro
Employment - Pacific Biosciences Research Center
Leadership - Pacific Biosciences Research Center
Stock and Other Ownership Interests - Pacific Biosciences Research Center; Pacific Biosciences Research Center
Honoraria - Pacific Biosciences Research Center; Pacific Biosciences Research Center
Consulting or Advisory Role - Pacific Biosciences Research Center
Research Funding - Pacific Biosciences Research Center (Inst)
Patents, Royalties, Other Intellectual Property - Detection of cancer using the alpha-fetoprotein receptor. (Inst)
Other Relationship - Pacific Biosciences Research Center
 
David Berz
Honoraria - AstraZeneca; Caris Life Sciences; EMD Serono; Jazz Pharmaceuticals; Mirati Therapeutics; OncoCyte; Sun Pharma
Consulting or Advisory Role - Jazz Pharmaceuticals; Sun Pharma
Speakers' Bureau - AstraZeneca; Biocept; Boehringer Ingelheim; Caris Life Sciences; EMD Serono; Jazz Pharmaceuticals; Mirati Therapeutics; natera; Novartis; OncoCyte; Sun Pharma